Carrier screening for Alport syndrome: The clinical importance of heterozygosity for pathogenic or likely pathogenetic variants.
Saved in:
| Title: | Carrier screening for Alport syndrome: The clinical importance of heterozygosity for pathogenic or likely pathogenetic variants. |
|---|---|
| Authors: | Souter V; Natera, Inc., Austin, Texas, USA., Johnson L; Natera, Inc., Austin, Texas, USA., Becraft E; Natera, Inc., Austin, Texas, USA., Cantu-Weinstein A; Natera, Inc., Austin, Texas, USA., Tabriziani H; Natera, Inc., Austin, Texas, USA., Benn P; UCONN Health, Farmington, Connecticut, USA., Kashtan CE; University of Minnesota Medical School, Minneapolis, Minnesota, USA. |
| Source: | Journal of genetic counseling [J Genet Couns] 2025 Jun; Vol. 34 (3), pp. e70045. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 9206865 Publication Model: Print Cited Medium: Internet ISSN: 1573-3599 (Electronic) Linking ISSN: 10597700 NLM ISO Abbreviation: J Genet Couns Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| ISSN: | 1573-3599 |
|---|---|
| DOI: | 10.1002/jgc4.70045 |
